UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (685) 685
humans (677) 677
endometrial neoplasms - enzymology (566) 566
science & technology (531) 531
life sciences & biomedicine (505) 505
endometrial neoplasms - pathology (327) 327
oncology (314) 314
endometrial cancer (281) 281
middle aged (280) 280
aged (229) 229
endometrial neoplasms - genetics (219) 219
adult (205) 205
cancer (162) 162
obstetrics & gynecology (156) 156
immunohistochemistry (155) 155
cell line, tumor (138) 138
endometrium - enzymology (107) 107
aged, 80 and over (100) 100
endometrial neoplasms - metabolism (94) 94
adenocarcinoma - enzymology (91) 91
animals (90) 90
endometrial neoplasms - drug therapy (90) 90
prognosis (90) 90
endometrial carcinoma (81) 81
neoplasm staging (80) 80
tumor cells, cultured (80) 80
endometrium (79) 79
carcinoma, endometrioid - enzymology (68) 68
gene expression regulation, neoplastic (67) 67
hematology, oncology and palliative medicine (61) 61
obstetrics and gynecology (61) 61
pathology (61) 61
apoptosis (60) 60
cell biology (59) 59
mutation (58) 58
analysis (57) 57
gene expression (56) 56
neoplasm invasiveness (56) 56
ovarian neoplasms - enzymology (56) 56
adenocarcinoma - pathology (54) 54
case-control studies (53) 53
endometrial hyperplasia - enzymology (51) 51
mice (49) 49
carcinoma, endometrioid - pathology (46) 46
apoptosis - drug effects (45) 45
carcinoma (45) 45
endometrium - pathology (45) 45
rna, messenger - genetics (45) 45
uterine neoplasms - enzymology (45) 45
reverse transcriptase polymerase chain reaction (44) 44
risk factors (43) 43
breast neoplasms - enzymology (42) 42
cell proliferation (42) 42
genetic aspects (42) 42
research (42) 42
tumors (41) 41
biochemistry & molecular biology (40) 40
proteins (40) 40
enzymes (38) 38
abridged index medicus (37) 37
carcinoma - enzymology (37) 37
ovarian cancer (37) 37
signal transduction (37) 37
blotting, western (36) 36
cell proliferation - drug effects (36) 36
gene expression regulation, enzymologic (36) 36
endocrinology & metabolism (35) 35
genetic predisposition to disease (35) 35
rna, messenger - metabolism (35) 35
male (34) 34
polymerase chain reaction (34) 34
ovarian neoplasms - pathology (33) 33
rna, messenger - biosynthesis (33) 33
antineoplastic agents - pharmacology (32) 32
carcinoma, endometrioid - genetics (32) 32
cell cycle (31) 31
health aspects (31) 31
proto-oncogene proteins c-akt - metabolism (31) 31
research article (31) 31
endometrium - metabolism (30) 30
estrogen (30) 30
transfection (30) 30
physiological aspects (29) 29
breast cancer (28) 28
aromatase - metabolism (27) 27
development and progression (27) 27
estradiol - pharmacology (27) 27
kinases (27) 27
mice, nude (26) 26
phosphatidylinositol 3-kinases - metabolism (26) 26
endometrial hyperplasia - pathology (25) 25
estrogens - metabolism (25) 25
genotype (25) 25
medicine (25) 25
multidisciplinary sciences (25) 25
phosphorylation (25) 25
polymorphism, genetic (25) 25
science & technology - other topics (25) 25
biomarkers, tumor - analysis (24) 24
biomarkers, tumor - metabolism (24) 24
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (669) 669
Russian (20) 20
Polish (10) 10
Chinese (8) 8
Japanese (6) 6
French (3) 3
German (3) 3
Czech (1) 1
Hebrew (1) 1
Italian (1) 1
Portuguese (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer chemotherapy and pharmacology, ISSN 1432-0843, 07/2019, Volume 84, Issue 3, pp. 487 - 499
Enzymes of the cytochrome P450 (CYP) subfamily 3A and 2C play a major role in the metabolism of taxane anticancer agents. While their function in hepatic... 
Intratumoral | Ritonavir | Paclitaxel | Docetaxel | CYP | Review | Journal Article | Medicine & Public Health | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Taxoids - pharmacology | Humans | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Lung Neoplasms - pathology | Male | Breast Neoplasms - enzymology | Female | Antineoplastic Agents - pharmacology | Cytochrome P-450 CYP2C8 - metabolism | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Endometrial Neoplasms - enzymology | Lung Neoplasms - enzymology | Neoplasms - enzymology | Breast Neoplasms - drug therapy | Ovarian Neoplasms - enzymology | Neoplasms - drug therapy | Breast Neoplasms - pathology | Cytochrome P-450 CYP3A - metabolism | Prostatic Neoplasms - enzymology | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Neoplasms - pathology | Antimitotic agents | Protease inhibitors | Proteases | Pharmacy | Cytochrome P-450 | Physiological aspects | Drugstores | Antineoplastic agents | Ovarian cancer | Cytochrome | Enzymes | Cytochrome P450 | Proteinase inhibitors | Taxane | Metabolism | Anticancer properties | Antitumor agents | Lungs | Drug metabolism | Breast | Solid tumors | Taxanes | Prostate | Endometrium | Tumors | Cytochromes P450 | Index Medicus
Journal Article
Genes & development, ISSN 0890-9369, 06/2006, Volume 20, Issue 12, pp. 1569 - 1574
Journal Article
Molecular and cellular endocrinology, ISSN 0303-7207, 02/2013, Volume 366, Issue 2, pp. 170 - 179
Journal Article
The Journal of pathology, ISSN 0022-3417, 07/2018, Volume 245, Issue 3, pp. 283 - 296
Genomic instability, which is a hallmark of cancer, is generally thought to occur in the middle to late stages of tumourigenesis, following the acquisition of... 
endometrial cancer | mutation | colorectal cancer | POLE | precursor lesion | polymerase proofreading | Pathology | Oncology | Life Sciences & Biomedicine | Science & Technology | Genomic Instability | Adenocarcinoma - pathology | Poly-ADP-Ribose Binding Proteins - metabolism | Colorectal Neoplasms - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Databases, Genetic | Tumor Microenvironment | Male | DNA Polymerase II - metabolism | Endometrial Neoplasms - immunology | Neoplasm Grading | Endometrial Neoplasms - genetics | Cell Transformation, Neoplastic - genetics | Antigens, Neoplasm - metabolism | CD8-Positive T-Lymphocytes - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Adenocarcinoma - genetics | DNA Polymerase II - genetics | Antigens, Neoplasm - genetics | Colorectal Neoplasms - enzymology | Genetic Predisposition to Disease | Endometrial Neoplasms - enzymology | Antigens, Neoplasm - immunology | Adenocarcinoma - immunology | Adenocarcinoma - enzymology | Poly-ADP-Ribose Binding Proteins - genetics | Gene Expression Profiling - methods | Cell Transformation, Neoplastic - metabolism | Whole Genome Sequencing | Cell Transformation, Neoplastic - immunology | Phenotype | Colorectal Neoplasms - immunology | Endometrial Neoplasms - pathology | Mutation | CD8-Positive T-Lymphocytes - immunology | Cell Transformation, Neoplastic - pathology | Colorectal Neoplasms - pathology | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Genetic aspects | Immune response | Carcinogenesis | Tumor antigens | Prognosis | Stability | Initiators | CD8 antigen | p53 Protein | Colorectal carcinoma | Lymphocytes T | Genomes | Molecular chains | Gene sequencing | Genomic instability | Carcinogens | Exonuclease | Precursors | Tumorigenesis | Lesions | Endometrium | Cancer | Tumors | Immune system | Index Medicus | Original Papers | Original Paper
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 12/2009, Volume 33, Issue 12, pp. 1869 - 1877
Endometrial carcinomas (ECs) in Young women (<= 40 y) are Usually managed conservatively in selected patients. Whether oophorectomy with total hysterectomy is... 
HNPCC/Lynch syndrome | Endometrial carcinoma | Young patients | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Immunohistochemistry | MutL Protein Homolog 1 | Nuclear Proteins - analysis | Age Factors | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Humans | Ovarian Neoplasms - pathology | DNA-Binding Proteins - analysis | Neoplasms, Multiple Primary | Ovarian Neoplasms - mortality | Carcinoma, Endometrioid - therapy | Patient Selection | Ovarian Neoplasms - genetics | Young Adult | Endometrial Neoplasms - genetics | Time Factors | Adenosine Triphosphatases - analysis | DNA Mismatch Repair | Adult | Female | Mismatch Repair Endonuclease PMS2 | Carcinoma, Endometrioid - genetics | Endometrial Neoplasms - enzymology | Carcinoma, Endometrioid - enzymology | Risk Assessment | Down-Regulation | Risk Factors | Treatment Outcome | DNA Repair Enzymes - analysis | Ovarian Neoplasms - enzymology | Adaptor Proteins, Signal Transducing - analysis | Biopsy | Carcinoma, Endometrioid - mortality | Adenocarcinoma, Clear Cell - therapy | Endometrial Neoplasms - therapy | Ovarian Neoplasms - therapy | Endometrial Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | MutS Homolog 2 Protein - analysis | Neoplasm Staging | Adenocarcinoma, Clear Cell - enzymology | Adenocarcinoma, Clear Cell - genetics | Carcinoma, Endometrioid - pathology | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article